Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI
Completed · Phase 3 · Has a placebo group
Conditions studied: Mucopolysaccharidosis VI
In brief
The purpose of the study is to evaluate the ability of rhASB versus placebo to enhance endurance in patients with Mucopolysaccharidosis VI (MPS VI), as evidenced by an increase in the number of meters walked in the 12 minute walk test at Week 24 compared with baseline.
Key facts
- Study ID
- NCT00067470
- Run by
- BioMarin Pharmaceutical
- People needed
- 39
- Starts
- 2003-09-01
- Expected to finish
- 2004-03-01
- Last updated by the study team
- 2009-12-24
Who can join
Age: 7 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient consent
- Patient must be seven years of age or older
- Patient must have documented biochemical or genetic proof of MPS VI
- The patient must be able to walk independently at least 5 meters and no more than 270 meters in the first 6 minutes, or no more then 400 meters total in 12 minutes, in the screening 12-minute walk test
- If female of childbearing potential, patient must have a negative pregnancy test
You may not qualify if…
- Patient is under consideration for or has undergone a successful bone marrow transplant (BMT)
- Patient refuses or is unable to complete all screening evaluations
- Pregnant or lactating patient
- Patient has received an investigational drug within 30 days prior to study enrollment
- Patient has been previously treated with rhASB
- Patient has a medical condition, serious intercurrent illness, or other extenuating circumstance that may significantly confound study results or decrease study compliance
- The patient has clinically significant spinal cord compression
- The patient has known hypersensitivity to rhASB or to components of the active or placebo test solutions
Where it is running
- BioMarin Pharmaceutical Inc. — Novato, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.